Cargando...
New Oral Anticoagulants in Nonvalvular Atrial Fibrillation
The choice of an oral anticoagulant (OAC) for patients with nonvalvular atrial fibrillation (NVAF) is a major and complex clinical decision taking into account the individual risk‐benefit ratio and bearing in mind the chronicity of therapy. This review focuses on the safety and efficacy of new oral...
Gardado en:
| Publicado en: | Clin Cardiol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley Periodicals, Inc.
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6490750/ https://ncbi.nlm.nih.gov/pubmed/27716952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22582 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|